7.1 Enteral Nutrition, Nasogastric Tube Placement & Safety

6.1 Enteral Nutrition, Nasogastric Tube Placement & Safety

In acute and community Irish healthcare settings, enteral tube feeding is an essential clinical intervention used to deliver macro- and micronutrients, fluids, and medications directly into the gastrointestinal tract. Registered General Nurses (RGNs) are responsible for inserting, verifying, maintaining, and administering feeds through nasogastric (NG) tubes. Because improper placement and management can result in catastrophic patient harm—including fatal pulmonary aspiration, tension pneumothorax, and refeeding collapse—strict adherence to Irish National Clinical Guidelines and Health Service Executive (HSE) Patient Safety Alerts is mandatory.

---

1. Enteral Nutrition vs. Parenteral Nutrition: Principles & Indications

The fundamental clinical dictum governing modern nutritional support is: "If the gut works, use it." Enteral nutrition (EN) delivers nutrients directly into the stomach or small intestine, whereas Total Parenteral Nutrition (TPN) bypasses the gastrointestinal tract entirely, delivering hypertonic elemental nutrients directly into a central venous catheter.

Physiological Superiority of the Enteral Route

1. Preservation of Gut Mucosal Architecture: The enterocytes of the intestinal villi derive over 70% of their energy directly from luminal nutrients. Lack of enteral stimulation leads to rapid villous atrophy, blunting of microvilli, and loss of tight mucosal junctions within 48 to 72 hours.
2. Prevention of Bacterial Translocation: Intact intestinal mucosal barriers prevent pathogenic gut microbiota and endotoxins from entering the portal and systemic circulations. Mucosal atrophy allows luminal bacteria to translocate into mesenteric lymph nodes, triggering systemic inflammatory response syndrome (SIRS), sepsis, and multi-organ failure.
3. Immune Function Preservation: Approximately 70% of the body's immune cells reside within the Gut-Associated Lymphoid Tissue (GALT) and Peyer's patches. Luminal feeding stimulates the synthesis of secretory immunoglobulin A (sIgA), which neutralises mucosal pathogens.
4. Metabolic & Hepatic Support: Enteral absorption maintains physiological portal blood flow, regulates insulin/glucagon homeostasis, and significantly reduces the incidence of cholestasis, fatty liver degeneration, and central catheter-related bloodstream infections (CRBSI) associated with TPN.

Clinical Indications: Enteral vs. Parenteral

---

2. Anatomical Sizing, Tube Types & Insertion Technique

Selecting the correct device and establishing the accurate anatomical insertion depth are crucial initial steps in preventing procedural trauma and misplacement.

Tube Selection: Fine-Bore vs. Wide-Bore

• Fine-Bore Polyurethane / Silicone Tubes (8–10 French Gauge [Fr]): Designed specifically for enteral feeding and medication administration. They are narrow, highly flexible, comfortable for the patient, cause minimal irritation to nasal and oesophageal mucosa, and can remain in situ for 4 to 8 weeks. They contain an internal flexible metal guide wire (stylet) that provides structural rigidity during insertion.
• Wide-Bore PVC / Ryle's Tubes (12–18 Fr): Stiff, large-lumen tubes designed exclusively for gastric decompression, aspiration of gastric contents, and gastric lavage in acute poisoning or bowel obstruction. They are not suitable for long-term enteral feeding due to mucosal ulceration, oesophageal sphincter incompetence, and patient discomfort.

Contraindications to Nasogastric Insertion

Before proceeding, the nurse must screen for critical contraindications:

• Suspected or Confirmed Basilar Skull Fracture / Severe Maxillofacial Trauma: Risk of intracranial passage through a fractured cribriform plate. Clinical signs include periorbital ecchymosis ("raccoon eyes"), mastoid ecchymosis ("Battle's sign"), haemotympanum, and clear cerebrospinal fluid (CSF) rhinorrhoea/otorrhoea.
• Oesophageal Pathology: Recent oesophageal banding or sclerotherapy for varices, known strictures, recent corrosive ingestion, or recent high-risk upper gastrointestinal surgery (e.g., oesophagectomy, gastric bypass) where insertion must only be performed under direct surgical/endoscopic guidance.
• Severe Uncorrected Coagulopathy: Risk of profuse epistaxis and airway compromise.

The NEX Measurement Protocol

To determine the individualised insertion length required for the tube tip to enter the stomach beyond the gastro-oesophageal junction, the nurse performs the standardized anatomical measurement:

$\text{Total Insertion Depth} = \text{NEX} + (5\text{ to }10\text{ cm})$

1. Measure from the tip of the patient's Nose to the lobe of the Ear (N to E).
2. Extend the tape or tube from the earlobe down to the tip of the Xiphisternum (E to X).
3. Add 5 to 10 cm: Anatomical cadaveric and radiographic studies confirm that standard NEX alone frequently leaves the tube tip and lateral eyelets resting in the lower oesophagus. Adding 5 to 10 cm ensures the tube passes through the lower oesophageal sphincter into the gastric body.
4. Note the precise centimetre mark on the tube that must align with the external entrance of the nares.

+---------------------------------------------------------------------------------+
|                        NEX + 5-10 CM MEASUREMENT SEQUENCE                       |
+---------------------------------------------------------------------------------+
|  [Nose Tip] ----> [Earlobe] ----> [Xiphisternum] ----> [Add 5 to 10 cm Margin]   |
|                                                                                 |
|  * Identifies the precise anatomical distance required to ensure that the tip   |
|    and all side aspiration eyelets clear the gastro-oesophageal junction.       |
+---------------------------------------------------------------------------------+

Step-by-Step Insertion Protocol (Irish Practice & OSCE Standard)

1. Preparation & Consent: Explain procedure, confirm identity against wristband, assess capacity, obtain informed consent, and establish a "stop signal" (e.g., patient raising a hand).
2. Patient Positioning: Place the patient in high Fowler's position (sitting upright at 60°–90°) with the head supported in a neutral position. If contraindicated, position in semi-Fowler's with a tilt. Inspect the nostril for septal deviation, polyps, or obstruction; select the clearer nostril.
3. Lubrication: Activate the hydromer coating with sterile water (if pre-lubricated) or coat the distal 10–15 cm of the tube with a generous amount of water-soluble lubricant (e.g., K-Y Jelly). Never use petroleum-based lubricants (liquid paraffin/Vaseline), which cause chemical lipoid pneumonia if aspirated.
4. Advancement to Oropharynx: Gently insert the tube into the nostril, advancing horizontally along the floor of the nasal cavity parallel to the palate (aiming backward toward the ear, never upward). When the tube enters the posterior pharynx (at approximately 10–15 cm), the patient may experience a gagging sensation.
5. Swallowing & Neck Flexion: Instruct the patient to flex their neck slightly forward (chin-to-chest). This anatomical posture closes the epiglottis over the laryngeal inlet and widens the oesophageal opening. Provide small sips of water via a straw (if swallowing is safe) or ask the patient to swallow saliva repeatedly. Advance the tube 5–10 cm synchronously with each swallow.
6. Recognising Airway Misplacement: If the patient exhibits severe coughing, cyanosis, stridor, aphonia (inability to speak), or acute respiratory distress, the tube has entered the trachea. STOP immediately, withdraw the tube back into the nasopharynx, reassure the patient, administer oxygen if necessary, and allow their breathing to recover before re-attempting.
7. Securing the Tube: Once advanced to the predetermined centimetre mark, secure the tube to the bridge of the nose using a dedicated commercial fixation device or split hypoallergenic tape. Ensure the tube does not press against the ala nasi (to avoid pressure necrosis).
8. Stylet Management: Never withdraw the internal guide wire until initial bedside pH checks or X-ray verification have occurred according to local hospital policy. NEVER reinsert a guide wire or stylet while the tube remains inside the patient, as it can perforate the tube wall and tear oesophageal or tracheal tissue.

---

3. Critical Safety Checks & Position Verification: HSE Standards

Under Irish National Clinical Guidelines and Health Service Executive (HSE) Quality and Patient Safety Directorate Alerts, misplacement of a nasogastric tube into the respiratory tract resulting in the administration of feed, fluid, or medication is classified as a reportable Never Event.

[!IMPORTANT] The Golden Rule of NG Tube Safety: Never introduce any fluid, water, feed, or medication down a nasogastric tube until its position in the stomach has been definitively verified by a valid, compliant method.

First-Line Bedside Verification: CE-Marked pH Testing

The primary bedside test to confirm gastric placement is testing fluid aspirated from the tube using CE-marked pH indicator paper (specifically graded in 0.5 increments from pH 0.0 to 6.0 or 7.0).

• Technique: Attach a 50–60 mL purple ENFit enteral syringe to the tube. Apply gentle, steady aspiration. Place a few drops of aspirate onto the indicator strip and compare against the manufacturer's colour scale.
• The Safe Benchmark: $\text{pH} \le 5.5$:
  • A pH of 5.5 or lower confirms that the aspirate is acidic, indicating true gastric juice. Enteral feeding, flushing, or medication administration may safely commence.
• Inconclusive Reading: $\text{pH} > 5.5$:
  • A pH of 6.0 or higher indicates either:
    1. Intestinal Fluid: Secretions from the duodenum or jejunum typically exhibit a pH of 6.0 to 8.0.
    2. Respiratory Fluid: Tracheobronchial secretions and pleural effusions typically exhibit a pH of 7.0 to 8.0.
    3. Neutralized Gastric Acid: Gastric acid may be suppressed in patients receiving Proton Pump Inhibitors (PPIs) (e.g., omeprazole, pantoprazole), H2-receptor antagonists (e.g., famotidine), or continuous enteral feeds.
  • Action: If pH is > 5.5, DO NOT FEED. Proceed to clinical troubleshooting or escalate for an X-ray.

Troubleshooting Failure to Obtain Aspirate

If no aspirate is obtained on initial suction:

1. Turn the patient onto their left lateral side for 10–15 minutes (this allows gastric fluid to pool along the greater curvature where the tube tip rests).
2. Insufflate 10–20 mL of air using an ENFit syringe to clear the tube tip from the gastric mucosa, then aspirate gently.
3. Wait 15 to 30 minutes and re-attempt aspiration (allowing gastric secretions to accumulate).
4. If safe and clinically permitted, offer the patient a small sip of water or mouth care.
5. If aspirate cannot be obtained after troubleshooting, the tube position cannot be confirmed at the bedside: request an urgent chest/abdominal X-ray.

Second-Line Gold Standard: Radiographic (X-Ray) Confirmation

A chest/abdominal X-ray is mandatory when:

• Bedside aspirate cannot be obtained despite troubleshooting.
• The aspirate pH remains persistently > 5.5.
• The patient is unconscious, critically ill, sedated, or has absent swallow/cough reflexes.

The 4-Point Radiographic Criteria (Irish National Standard)

A qualified medical practitioner or credentialed nurse specialist must formally view the digital radiograph and record in the clinical notes that the tube satisfies all four criteria:

+---------------------------------------------------------------------------------+
|              THE 4-POINT RADIOGRAPHIC VERIFICATION CRITERIA                     |
+---------------------------------------------------------------------------------+
| 1. PATHWAY:      Tube descends vertically down the midline of the thorax.       |
| 2. CARINA:       Tube bisects the carina (midline between right and left main   |
|                  bronchi), ruling out bronchial intubation.                     |
| 3. DIAPHRAGM:    Tube crosses the diaphragm in the midline.                     |
| 4. GASTRIC TIP:  The tube tip and all side eyelets are clearly visible below   |
|                  the left hemi-diaphragm in the gastric air bubble, at least    |
|                  10 cm beyond the gastro-oesophageal junction.                  |
+---------------------------------------------------------------------------------+

[!CAUTION] X-Ray Confirmation Rule: The radiograph must show the upper abdomen, not just the chest. If the tip cannot be clearly visualized below the diaphragm, the X-ray is inadequate, and the tube must not be used.

Strictly Prohibited "Never Events" in Irish Practice

The following outdated methods are clinically unreliable, dangerous, and strictly banned under HSE patient safety directives:

---

4. Ongoing Nursing Care, Administration & Complication Prevention

Once accurate placement is established, meticulous ongoing nursing management is required to maintain tube patency, preserve skin integrity, and prevent pulmonary aspiration.

Timing & Frequency of Verification

Bedside pH verification must be executed and recorded in the patient's nursing notes:

• Before administering every bolus feed.
• Before administering any medication.
• At least once every 24 hours (or at the start of every nursing shift) during continuous infusion feeds.
• Immediately following any episode of vomiting, retching, vigorous coughing, or deep tracheal suctioning.
• Whenever the external centimetre mark at the nares shifts or indicates migration.

Aspiration Prevention & Patient Positioning

Pulmonary microaspiration of gastric contents is a major cause of hospital-acquired pneumonia. The RGN must implement the following safeguards:

• Bed Elevation: Maintain the head of the bed elevated to 30° to 45° at all times during active enteral infusion.
• Post-Feed Elevation: For intermittent or bolus feeds, keep the patient upright at 30° to 45° during administration and for at least 30 to 60 minutes after the feed finishes.
• Gastric Residual Volume (GRV): Routine excessive aspirating of GRV is no longer recommended as it clogs fine-bore tubes and disrupts electrolyte balance. However, if the patient exhibits abdominal distension, nausea, vomiting, or signs of reflux, assess gastric emptying and temporarily pause feeding.

Flushing Protocols & ENFit Technology

• Syringe Standard: All enteral flushes, feeds, and oral liquid medications must be administered using dedicated purple-coloured ENFit syringes (ISO 80369-3 standard). The reverse-threaded ENFit design makes it physically impossible to connect enteral equipment to intravenous luer-lock lines, eliminating accidental IV administration of enteral feed.
• Volume & Fluid: Flush with 30 mL of water (sterile water for critically ill, immunocompromised, or post-surgical patients; fresh potable tap water for stable ward patients per hospital policy):
  • Before and after every feed.
  • Before and after every medication dose (flush with 10–15 mL of water between individual medications to prevent drug-drug interactions and precipitation).
  • Every 4 to 6 hours during continuous enteral infusions.
• Syringe Size: Always use a 50 mL or 60 mL ENFit syringe for flushing. Small syringes (10 mL or 20 mL) generate excessive intraluminal hydrostatic pressure ($P = F/A$) that can rupture fine-bore polyurethane tubes.

Managing & Preventing Tube Blockages

• Primary Cause: Inadequate flushing, administering crushed tablets that have not been finely pulverized, mixing incompatible drugs, or reaction between acidic medications and protein-rich enteral formulas.
• Troubleshooting: If an obstruction occurs, attach a 50 mL ENFit syringe, gently instill warm water, and apply gentle push-pull plunger motion. Allow warm water to sit in the tube for 15–20 minutes to soften the plug. If unsuccessful, consider pancreatic enzyme solution mixed with sodium bicarbonate (if prescribed under hospital protocol).
• Banned Solvents: Never use carbonated cola drinks or acidic fruit juices (cranberry/orange). The acidity denatures the proteins in the enteral feed, precipitating heavy clumping and worsening the blockage.

---

5. Refeeding Syndrome: Pathophysiology & Management

Refeeding syndrome is a severe, potentially fatal metabolic complication that occurs when nutritional support is reintroduced to severely malnourished or starved individuals.

Pathophysiology

During prolonged starvation (greater than 5 to 7 days), the body switches its primary energy substrate from carbohydrates to ketone bodies and fatty acids, down-regulating insulin secretion. Intracellular stores of phosphate, potassium, and magnesium become severely depleted, although circulating serum levels may remain normal due to homeostatic compensatory mechanisms.

When enteral carbohydrates are reintroduced:

1. Insulin Surge: Glucose absorption triggers a sudden, massive release of pancreatic insulin.
2. Intracellular Shift: Insulin drives glucose, potassium, magnesium, and phosphate out of the vascular space and into the cells to fuel glycogen synthesis and glycolysis.
3. Profound Hypophosphataemia: Serum phosphate drops catastrophically. Because phosphate is essential for the production of adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (2,3-DPG), cellular energy failure ensues.
4. Clinical Manifestations:
   • Cardiovascular: Myocardial dysfunction, acute heart failure, lethal ventricular arrhythmias (torsades de pointes), hypotension.
   • Neuromuscular: Muscle weakness, diaphragmatic fatigue resulting in acute respiratory failure, paresthesia, tetany, seizures, encephalopathy.
   • Haematological: Impaired oxygen delivery to tissues, haemolytic anaemia, leukocyte dysfunction.

+---------------------------------------------------------------------------------+
|                     REFEEDING SYNDROME PATHOPHYSIOLOGY                          |
+---------------------------------------------------------------------------------+
|  Prolonged Starvation / Malnutrition (Intracellular Phosphate Depletion)        |
|                                    │                                            |
|                                    ▼                                            |
|  Reintroduction of Enteral Carbohydrates / Glucose                              |
|                                    │                                            |
|                                    ▼                                            |
|  Massive Pancreatic Insulin Secretion Surge                                     |
|                                    │                                            |
|                                    ▼                                            |
|  Rapid Shift of PO4, K+, and Mg2+ into Cells (alongside water and glucose)       |
|                                    │                                            |
|                                    ▼                                            |
|  PROFOUND HYPOPHOSPHATAEMIA, HYPOKALAEMIA, HYPOMAGNESAEMIA                      |
|                                    │                                            |
|                                    ▼                                            |
|  ATP Depletion -> Acute Heart Failure, Diaphragmatic Collapse, Arrhythmias, Coma|
+---------------------------------------------------------------------------------+

High-Risk Criteria & Nursing Interventions (Irish / NICE Guidelines)

Patients are considered at high risk for refeeding syndrome if they have:

• BMI < 16 kg/m² or unintentional weight loss > 15% in the preceding 3 to 6 months.
• Negligible food intake for > 10 days.
• Low baseline levels of phosphate, potassium, or magnesium prior to feeding.
• History of alcohol misuse, chronic anorexia nervosa, or severe malabsorption (e.g., Crohn's disease).

Evidence-Based Nursing Management:

1. Pre-Feed Bloods: Check baseline serum electrolytes (phosphate, magnesium, potassium, calcium) and renal profile before starting nutrition.
2. Thiamine Supplementation: Administer intravenous Pabrinex (Thiamine / Vitamin B Complex) or high-dose oral thiamine at least 30 minutes before starting the feed to prevent acute Wernicke-Korsakoff encephalopathy and lactic acidosis.
3. Start Low, Go Slow: Initiate feeds at a reduced rate: 10 kcal/kg/day (or as low as 5 kcal/kg/day in extreme malnutrition). Slowly titrate upward over 4 to 7 days toward full nutritional requirements while monitoring biochemistries daily.
4. Daily Monitoring: Measure serum phosphate, potassium, and magnesium daily for the first 5 to 7 days. Promptly replace electrolytes intravenously or enterally as prescribed.

---

6. Clinical Pitfalls & OSCE Station Traps